Quick links: United States | Major Indices | Indices Future | Real-time Commodities | Webinars | Coronavirus | Economic Calendar
18 Mar 2022
Moderna Seeks FDA Approval for Second COVID Booster Shot for Adults
The Index Today
Moderna sought to obtain an emergency authorization late Thursday from the U.S. Food & Drug Administration (FDA) department for a second COVID-19 booster dose for adults following the present surge in cases around the world.
According to Reuters, the U.S.-based biotechnology firm revealed that they are seeking to have a booster vaccine for people over the age of 18 years, especially those who are more vulnerable to contracting the coronavirus that can be appropriately sanctioned by the U.S. Centers for Disease Control and Prevention (CDC) and other healthcare officials.
This comes after Pfizer-BioNTech requested approval last week for a second COVID dose for people over 65 years of age. However, Moderna’s second COVID vaccine seeks to cover and offer immunity to a larger group of people. Prominent biopharmaceutical companies have been seeking to develop and implement booster shots as an increasing number of COVID-19 variants continue to emerge.
©Photo: Financial Times